BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29895389)

  • 1. Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography.
    Liu Y; Wang M; Ji R; Cang L; Gao F; Shi Y
    Clin Radiol; 2018 Oct; 73(10):865-872. PubMed ID: 29895389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study.
    Shi Y; Gao F; Li Y; Tao S; Yu B; Liu Z; Liu Y; Glaser KJ; Ehman RL; Guo Q
    Eur Radiol; 2018 Mar; 28(3):936-945. PubMed ID: 28986646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis and severity assessment of acute pancreatitis (AP) using MR elastography (MRE) with spin-echo echo-planar imaging.
    Shi Y; Liu Y; Liu YQ; Gao F; Li JH; Li QJ; Guo QY
    J Magn Reson Imaging; 2017 Nov; 46(5):1311-1319. PubMed ID: 28252868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance elastography-derived stiffness: potential imaging biomarker for differentiation of benign and malignant pancreatic masses.
    Liu D; Chen J; Zhang Y; Dai Y; Yao X
    Abdom Radiol (NY); 2023 Aug; 48(8):2604-2614. PubMed ID: 37237155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
    Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
    AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection.
    Dyvorne HA; Jajamovich GH; Bane O; Fiel MI; Chou H; Schiano TD; Dieterich D; Babb JS; Friedman SL; Taouli B
    Liver Int; 2016 May; 36(5):659-66. PubMed ID: 26744140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
    Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
    Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large Duct Pancreatic Ductal Adenocarcinoma: A Morphological Variant of Pancreatic Ductal Adenocarcinoma With Distinct CT and MRI Characteristics.
    Choi SJ; Kim SJ; Kim DW; Lee SS; Hong SM; Kim KW; Kim JH; Kim HJ; Byun JH
    Korean J Radiol; 2023 Dec; 24(12):1232-1240. PubMed ID: 38016682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.